Chorionic gonadotropin in weight control. A double-blind crossover study
R. L. Young, R. J. Fuchs and M. J. Woltjen
Two hundred two patients participated in a double-blind random cross-over
study of the effectiveness of human chorionic gonadotropin (HCG) vs placebo
in a wieght reduction program. Serial measurements were made of weight,
skin-fold thickness, dropout rates, reasons for dropping out, and patient
subjective response. There was no statistically significant difference
between those receiving HCG vs placebo during any phase of this study (P
greater than .1).
